
IASLC/LinkedIn
Jul 3, 2025, 07:44
In Resectable EGFR-mutant NSCLC, the Path Forward Isn’t Always Straightforward – IASLC
International Association for the Study of Lung Cancer shared a post on LinkedIn:
“In resectable EGFR-mutant NSCLC, the path forward isn’t always straightforward.
In the latest episode of Lung Cancer Considered, Dr. Stephen Liu moderates a Virtual Tumor Board case with Drs. Chunxia Su and Collin Blakely. Together, they explore how to approach diagnosis, multidisciplinary planning, and treatment strategies for this unique patient population.
Read More About Non-Small Cell Lung Cancer on OncoDaily’s Article.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 3, 2025, 09:50
Jul 3, 2025, 08:53
Jul 3, 2025, 08:39
Jul 3, 2025, 08:27